Merck (MRK) Capital Expenditures Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
-36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
54.04% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
31.95% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.77% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-25.38% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
73.24% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
12.50% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-22.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
33.46% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-25.38% |
| Dec 31, 2025 |
10.25% |
| Sep 30, 2025 |
26.05% |
| Jun 30, 2025 |
-3.41% |
| Mar 31, 2025 |
54.24% |
| Dec 31, 2024 |
-5.26% |
| Sep 30, 2024 |
-13.19% |
| Jun 30, 2024 |
-18.03% |
| Mar 31, 2024 |
-14.50% |
| Dec 31, 2023 |
-13.93% |
| Sep 30, 2023 |
-19.89% |
| Jun 30, 2023 |
-14.53% |
| Mar 31, 2023 |
2.34% |
| Dec 31, 2022 |
-4.88% |
| Sep 30, 2022 |
-3.92% |
| Jun 30, 2022 |
14.50% |
| Mar 31, 2022 |
-9.06% |
| Dec 31, 2021 |
-15.58% |
| Sep 30, 2021 |
288.08% |
| Jun 30, 2021 |
73.90% |
| Mar 31, 2021 |
9.74% |
| Dec 31, 2020 |
38.53% |
| Sep 30, 2020 |
-68.51% |
| Jun 30, 2020 |
-27.49% |
| Mar 31, 2020 |
65.71% |
| Dec 31, 2019 |
11.19% |
| Sep 30, 2019 |
46.86% |
| Jun 30, 2019 |
34.13% |
| Mar 31, 2019 |
32.22% |
| Dec 31, 2018 |
29.93% |
| Sep 30, 2018 |
48.07% |
| Jun 30, 2018 |
48.35% |
| Mar 31, 2018 |
32.74% |
| Dec 31, 2017 |
29.76% |
| Sep 30, 2017 |
7.82% |
| Jun 30, 2017 |
4.80% |
| Mar 31, 2017 |
21.51% |
| Dec 31, 2016 |
11.76% |
| Sep 30, 2016 |
29.43% |
| Jun 30, 2016 |
38.38% |
| Mar 31, 2016 |
37.44% |
| Dec 31, 2015 |
0.61% |
| Sep 30, 2015 |
-1.25% |
| Jun 30, 2015 |
-10.26% |
| Mar 31, 2015 |
-0.98% |
| Dec 31, 2014 |
14.22% |
| Sep 30, 2014 |
-9.86% |
| Jun 30, 2014 |
-26.88% |
| Mar 31, 2014 |
-41.60% |
| Dec 31, 2013 |
-44.86% |
| Sep 30, 2013 |
-14.25% |
| Jun 30, 2013 |
-4.18% |
| Mar 31, 2013 |
6.04% |
| Dec 31, 2012 |
29.02% |
| Sep 30, 2012 |
-3.94% |
| Jun 30, 2012 |
18.08% |
| Mar 31, 2012 |
2.16% |
| Dec 31, 2011 |
-8.64% |
| Sep 30, 2011 |
27.51% |
| Jun 30, 2011 |
8.31% |
| Mar 31, 2011 |
-5.54% |
| Dec 31, 2010 |
18.41% |
| Sep 30, 2010 |
11.44% |
| Jun 30, 2010 |
-7.72% |
| Mar 31, 2010 |
45.90% |
